Table 2.
Comparison of effective rate and safety between the two groups (n (%)).
| Group | Number | Efficacy rate | Security | ||||
|---|---|---|---|---|---|---|---|
| Excellent | Improve | Invalid | Diarrhea | Abnormal liver and kidney | Allergic skin rash | ||
| Combined group | 68 | 53 (77.94) | 13 (19.12) | 2 (2.94) | 1 (1.47) | 0 (0.00) | 0 (0.00) |
| Western medicine group | 68 | 41 (60.29) | 10 (14.71) | 17 (25.00) | 2 (2.94) | 1 (1.47) | 0 (0.00) |
| x 2 | — | 13.765 | 1.030 | ||||
| P | — | 0.000 | 0.310 | ||||